Altea Therapeutics
closedAltea Therapeutics Corporation develops and commercializes transdermal drug delivery systems.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD19—28m (Dealroom.co estimates May 2009.)
Atlanta Georgia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$17.0m | Series B | ||
$30.0m | Series C | ||
$32.8m | Series C | ||
| N/A | $3.0m | Early VC | |
| N/A | $685k | Debt | |
N/A | Acquisition | ||
| Total Funding | AUD128m | ||